Vanda Pharmaceuticals Inc.
$321.69M- Market cap
- $328.31M
- Debt
- +$78.23M
- Cash
- −$84.85M
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VNDA · current priceP/S 1.52x
$5.43Latest market snapshot
Implied fair value · at AKR's multiple
$24.25346.5% above market
3.57 VNDA revenue / share×6.78x AKR P/S=$24.25
Market $5.43Implied $24.25
AKR · current priceP/S 6.78x
$20.29Latest market snapshot
Implied fair value · at VNDA's multiple
$4.5477.6% below market
2.99 AKR revenue / share×1.52x VNDA P/S=$4.54
Market $20.29Implied $4.54